McKesson Corporation

(New York Stock Exchange)

McKesson (MCK) stock at a glance

Full McKesson report
Ticker
MCK
Exchange
New York Stock Exchange
News sentiment ยท last 30 days
+63 Bullish
30-day average of 6 articles ยท scale โˆ’100 to +100

Across 6 scored articles from Oct 16 to Nov 14, 2026 (UTC), the average sentiment of McKesson news is Bullish (+63) on a scale from โˆ’100 to +100.

+75 Bullish 1 article

Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.

Articles

42
Show Summary
Show Bulletpoints
Detailed View
Bullish +75

Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?

McKesson Corporation (MCK), a leading prescription drug distributor within the Zacks Medical - Dental Supplies industry, has demonstrated a strong track record of consistently beating earnings estimates. The company achieved average surprise margins of 5.43% over its previous two quarters, having recently reported actual earnings of $9.34 per share against an expected $9.31, representing a 0.32% beat, and previously reporting $9.86 per share versus an estimate of $8.92 for a 10.54% surprise. Analysts tracking McKesson have noted a favorable shift in sentiment leading into the next quarterly report, highlighted by a positive Zacks Earnings ESP of +0.37%. This metric compares the most accurate current analyst estimate against the broader consensus and serves as an indicator that analysts are revising expectations upward based on incoming information. When combined with McKesson's Zacks Rank of #3 (Hold), historical data suggests such a combination produces a positive earnings surprise nearly 70% of the time, with the company expected to release its next earnings report on May 7, 2026. While past performance is indicative, the article emphasizes that earning beats do not always correlate directly with stock price increases and vice versa, making metrics like the Earnings ESP and Zacks Rank valuable tools for prediction. Zacks Investment Research recommends checking these metrics before quarterly releases to improve investment success rates and provides a broader list of stocks they believe are undervalued by Wall Street, citing that their Zacks Rank system has averaged +23.89% annual returns since 1988.

๐Ÿ“ˆ McKesson beats earnings estimates consistently with a recent positive surprise of 0.32%.

๐Ÿค– Positive analyst revisions suggest roughly 70% probability for another earnings beat ahead.

๐Ÿ—“๏ธ Next earnings report scheduled for May 7, 2026, though exact time remains unclear.

๐Ÿš€ Zacks promotes its filter to uncover stocks before reports using independent research tools.

๐Ÿ“Š Historical Zacks Rank system tracks annual returns averaging +23.89% since 1988.

๐Ÿ“ˆ McKesson (MCK) has beaten earnings estimates for the previous two quarters, with an average surprise of 5.43%.

๐Ÿ’ฐ The most recent quarter showed $9.34 per share earnings against a $9.31 expectation, representing a 0.32% positive surprise.

๐Ÿ“Š The prior quarter delivered $9.86 per share compared to an $8.92 consensus estimate, resulting in a 10.54% positive surprise.

๐Ÿ“‰ Analysts have revised their estimates positively for McKesson, resulting in a current Earnings ESP of +0.37%.

๐Ÿค– Zacks Rank #3 (Hold) combined with the positive Earnings ESP suggests nearly a 70% probability of another earnings beat.

๐Ÿ—“๏ธ The next earnings report is expected to be released on May 7, 2026.

โš ๏ธ A negative Earnings ESP reduces predictive power but does not necessarily indicate an earnings miss.

๐Ÿ’ก Analyst estimate revisions are considered a key factor that drives stock prices according to Zacks research.

๐Ÿ” The article promotes using the Earnings ESP Filter to uncover stocks before they report earnings.

๐Ÿ“‰ Stock #1 is described as a disruptive force with notable growth and resilience in the recommendation section.

๐Ÿ“ˆ Stock #2 shows bullish signs signaling investors to buy the dip.

๐Ÿ† Stock #3 is labeled as one of the most compelling investments currently available in the market.

๐Ÿ”ฅ Stock #4 is a leader in a red-hot industry poised for growth.

๐ŸŒ Stock #5 features a modern omni-channel platform coiled to spring for expansion.

๐Ÿ“Š Previous stock recommendations have historically soared with gains of +171%, +209%, and +232%.

๐Ÿš€ The free report highlights 7 best stocks expected to perform well over the next 30 days.

๐Ÿ’ผ Zacks Investment Research offers independent research tools like the Price Response Indicator and Earnings ESP.

๐Ÿ“ˆ Since 1988, the Zacks Rank system has averaged +23.89% annual returns for investors.

Bullish Signals
  • McKesson beats earnings with 5.43% average surprise over past two quarters.
  • Recent quarter EPS of $9.34 beat estimate of $9.31 by 0.32%.
  • Previous quarter delivered 10.54% positive surprise on earnings beat.
  • Zacks Earnings ESP is +0.37%, indicating bullish analyst revisions.
  • Positive Zacks Rank #3 ESP historically produces earnings beats 70% of time.
Risk Factors
  • Earnings surprise fell from 10.54% beat to 0.32% beat.
  • Analysts marginally bullish with +0.37% Earnings ESP.
  • Zacks Rank #3 (Hold) limits stock price upside.
Bullish Signals
  • McKesson (MCK) has an established history of consistently beating earnings estimates, with an average surprise of 5.43% over the past two quarters.
  • The most recent quarter saw a reported EPS of $9.34 per share, surpassing the expected estimate of $9.31 per share by 0.32%. The previous quarter delivered a stronger beat with $9.86 actual earnings against an $8.92 consensus, a 10.54% positive surprise.
  • McKesson currently holds a favorable Zacks Earnings ESP of +0.37%, indicating analysts have recently revised their estimates upward and are bullish on the company's earnings prospects for the upcoming quarter.
  • The stock carries a Zacks Rank #3 (Hold), which when combined with a positive Earnings ESP has historically produced an earnings beat nearly 70% of the time according to Zacks research.
  • Analysts revising their estimates right before an earnings release provide the most accurate prediction, and McKesson's current positive signal suggests another earnings beat could be imminent.
Risk Factors
  • McKesson's earnings surprises have been declining, dropping from a 10.54% beat in the previous quarter to just a 0.32% beat in the most recent quarter.
  • The positive Earnings ESP of +0.37% indicates analysts are only marginally bullish on earnings prospects, suggesting limited upside potential compared to stronger historical performance.
  • While McKesson holds a Zacks Rank #3 (Hold), this neutral rating combined with modest EPS beats may not be sufficient to drive significant stock price appreciation beyond consensus expectations.
Neutral 0

McKesson Corporation (MCK) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

McKesson Corporation (MCK) participated in a presentation during the Barclays 28th Annual Global Healthcare Conference held on March 11, 2026. The session opened with remarks from Glen Santangelo of Barclays Bank PLC's Research Division, who introduced Britt Vitalone, the Chief Financial Officer of the company, as a special guest for this particular engagement. Santangelo noted that while there had been significant market reaction following a press release regarding Vitalone's retirement decision, he clarified that his departure is scheduled to be completed over the next few months. Crucially, Santangelo emphasized that Vitaloneโ€™s retirement does not signal any strategic shifts, explicitly stating there is no change to the companyโ€™s existing financial guidance. The transcript excerpt provided focuses primarily on the management transition announcement rather than operational or financial details typically covered in such conferences. The market reaction mentioned by Santangelo suggests investors closely monitor leadership changes within McKesson's drug wholesaling group. While specific future earnings projections or operational metrics were not detailed in the provided text, the presentation context confirms that Barclays analysts are actively covering the drug wholesaling segment and consider the outgoing CFOโ€™s long tenure and recent retirement news to be significant events warranting a dedicated segment of their conference calls. The tone set by Santangelo was one of stability regarding forward-looking guidance despite the executive change, aiming to reassure investors that the company's trajectory remains unaffected by Vitalone stepping down to retire in Sarasota.

๐Ÿ“… McKesson hosted a healthcare conference presentation on March 11, 2026.

๐Ÿ’ผ CFO Britt Vitalone announced retirement due to relocation plans.

โœ… Management confirms no changes to strategic guidance or financial outlook.

๐ŸŒ Vitalone will retire to golf in Sarasota with colleagues.

๐Ÿ“‰ Analysts note stock reaction reflects strong employee valuation.

๐Ÿ“… McKesson Corporation (MCK) hosted a presentation at Barclays' 28th Annual Global Healthcare Conference on March 11, 2026.

๐Ÿ’ผ Britt Vitalone, currently serving as Chief Financial Officer of the company, announced his retirement after several months in role.

๐ŸŒ๏ธ Britt Vitalone has decided to retire and will move to Sarasota, Florida, to enjoy golfing with colleagues.

๐Ÿ“‰ Analyst Glen Santangelo noted that stock price reaction following a press release regarding Britt's retirement indicates high employee valuation.

โœ… Management emphasized that Britt's retirement is unrelated to any financial guidance changes or company direction.

๐ŸŽ™๏ธ The presentation focused on the drug wholesaling group, which Barclays analyst Glen Santangelo covers.

๐Ÿšซ No immediate changes to McKesson's strategic guidance will occur following Britt Vitalone's departure.

Bullish Signals
  • Company guidance unchanged after Britt Vitalone's retirement.
  • Stock rose on announcement, confirming leadership value.
Risk Factors
  • CFO Britt Vitalone retiring after months signals instability.
  • Only 2 months left in role raises continuity concerns.
Bullish Signals
  • No change to company guidance despite Britt Vitalone's retirement, signaling stability in management transition.
  • Stock market reacted positively to the announcement of Britt Vitalone's retirement, reflecting strong confidence in his past contributions and leadership value.
Risk Factors
  • The CFO, Britt Vitalone, announced his retirement effective after a couple of more months, leading to an immediate stock price reaction the day the press release came out, signaling negative market sentiment toward leadership stability.
  • McKesson's outgoing CFO Britt Vitalone is only with the company for a couple of more months before retiring to Sarasota, raising concerns about executive continuity and potential transition risks.